ARTICLE | Distillery Therapeutics
Cancer
September 26, 2018 5:39 PM UTC
Mouse studies suggest combining reactive nitrogen species neutralizers with inhibitors of CTLA-4, PD-1 and other immune checkpoints could help treat castration-resistant prostate cancer (CRPC) and lun...
BCIQ Company Profiles